Literature DB >> 15907579

Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.

Gigi N C Chiu1, Sheela A Abraham, Ludger M Ickenstein, Rebecca Ng, Göran Karlsson, Katarina Edwards, Ellen K Wasan, Marcel B Bally.   

Abstract

In the present study, doxorubicin was encapsulated into two thermosensitive liposome formulations which were composed of DPPC/MSPC/DSPE-PEG(2000) (90/10/4 mole ratio) or DPPC/DSPE-PEG(2000) (95/5 mole ratio). Doxorubicin loading was achieved through the use of a pH gradient or a novel procedure that involved doxorubicin complexation with manganese. Regardless of the initial drug-to-lipid ratios (D:L), the final D:L reached a maximum of 0.05 (w/w) when doxorubicin was encapsulated via a pH gradient for both thermosensitive liposome formulations. In contrast, the final maximum D:L achieved through manganese complexation was 0.2 (w/w), and this loading method did not affect temperature-induced drug release, with 85% of drug released from MSPC-containing liposomes within 10 min at 42 degrees C but <5% released over 60 min at 37 degrees C. When the thermosensitive liposomes prepared via the two different loading methods were injected into mice, similar plasma elimination profiles were observed. Cryo-transmission electron microscopy analysis indicated the presence of doxorubicin fiber bundles in liposomes loaded via pH gradient, compared to a stippled and diffuse morphology in those loaded via manganese complexation. To investigate the effect of intraliposomal pH on drug precipitate morphology, the A23187 ionophore (mediates Mn(2+)/H(+) exchange) was added to liposomes loaded with doxorubicin-manganese complex, and the stippled and diffuse appearance could be converted to one exhibiting fiber bundles after acidification of the liposome core. This suggests that the formation of doxorubicin-manganese complex is favored when the intraliposomal pH is >6.5. During the conversion to the fiber bundle morphology, no doxorubicin release was observed when A23187 was added to liposomes exhibiting a 0.05 (w/w), whereas a significant release was noted when the initial D:L was 0.2 (w/w). Following acidification of the liposomal interior and establishment of an apparent new D:L equilibrium, the measured D:L ratio was 0.05 (w/w). In conclusion, the manganese complexation loading method increased the encapsulation efficiency of doxorubicin in thermosensitive liposomes with no major impact on temperature-triggered drug release or pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907579     DOI: 10.1016/j.jconrel.2005.02.009

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.

Authors:  Azadeh Kheirolomoom; Lisa M Mahakian; Chun-Yen Lai; Heather A Lindfors; Jai Woong Seo; Eric E Paoli; Katherine D Watson; Eric M Haynam; Elizabeth S Ingham; Li Xing; R Holland Cheng; Alexander D Borowsky; Robert D Cardiff; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-12-06       Impact factor: 4.939

Review 2.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating.

Authors:  Terence Ta; Elizabeth Bartolak-Suki; Eun-Joo Park; Kavon Karrobi; Nathan J McDannold; Tyrone M Porter
Journal:  J Control Release       Date:  2014-08-23       Impact factor: 9.776

4.  Tumor-specific delivery of gemcitabine with activatable liposomes.

Authors:  Samantha T Tucci; Azadeh Kheirolomoom; Elizabeth S Ingham; Lisa M Mahakian; Sarah M Tam; Josquin Foiret; Neil E Hubbard; Alexander D Borowsky; Mo Baikoghli; R Holland Cheng; Katherine W Ferrara
Journal:  J Control Release       Date:  2019-07-10       Impact factor: 9.776

5.  Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for triggered release of doxorubicin.

Authors:  Terence Ta; Anthony J Convertine; Christopher R Reyes; Patrick S Stayton; Tyrone M Porter
Journal:  Biomacromolecules       Date:  2010-08-09       Impact factor: 6.988

Review 6.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

7.  Multi-stimuli-responsive, liposome-crosslinked poly(ethylene glycol) hydrogels for drug delivery.

Authors:  Luisa L Palmese; Ming Fan; Rebecca A Scott; Huaping Tan; Kristi L Kiick
Journal:  J Biomater Sci Polym Ed       Date:  2020-12-22       Impact factor: 3.517

Review 8.  Thermosensitive liposomal drug delivery systems: state of the art review.

Authors:  Barbara Kneidl; Michael Peller; Gerhard Winter; Lars H Lindner; Martin Hossann
Journal:  Int J Nanomedicine       Date:  2014-09-16

9.  Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.

Authors:  Agata Jabłońska-Trypuć; Grzegorz Świderski; Rafał Krętowski; Włodzimierz Lewandowski
Journal:  Molecules       Date:  2017-07-04       Impact factor: 4.411

10.  Bubble-Manipulated Local Drug Release from a Smart Thermosensitive Cerasome for Dual-Mode Imaging Guided Tumor Chemo-Photothermal Therapy.

Authors:  Suhui Sun; Sujuan Sun; Yan Sun; Ping Wang; Jianlun Zhang; Wenjing Du; Shumin Wang; Xiaolong Liang
Journal:  Theranostics       Date:  2019-10-18       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.